1.Looney, RJ, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clinical Immunology 1999; 90: 213–219.
2.Chidrawar, S, et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clinical and Experimental Immunology 2009; 155: 423–432.
3.Almanzar, G, et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. Journal of Virology 2005; 79: 3675–3683.
4.Pawelec, G, et al. Cytomegalovirus and human immunosenescence. Reviews in Medical Virolology 2009; 19: 47–56.
5.Derhovanessian, E, Larbi, A, Pawelec, G. Biomarkers of human immunosenescence: impact of cytomegalovirus infection. Current Opinions in Immunology 2009; 21: 440–445.
6.Roberts, ET, et al. Cytomegalovirus antibody levels, inflammation, and mortality among elderly latinos over 9 years of follow-up. American Journal of Epidemiology 2010; 172: 363–371.
7.Wang, GC, et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. American Journal of Epidemiology 2010; 171: 1144–1152.
8.Dowd, JB, Aiello, AE, Alley, DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiology and Infection 2009; 137: 58–65.
9.Staras, SA, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clinical Infectious Disease 2006; 43: 1143–1151.
10.Schoenmaker, M, et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. European Journal of Human Genetics 2006; 14: 79–84.
11.Westendorp, RG, et al. Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. Journal of the American Geriatric Society 2009; 57: 1634–1637.
12.Skytthe, A, et al. The Danish Twin Registry in the new millennium. Twin Research and Human Genetics 2006; 9: 763–771.
13.Bathum, L, et al. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clinical Chemistry 2001; 47: 81–87.
14.McGue, M. When assessing twin concordance, use the probandwise not the pairwise rate. Schizophrenia Bulletin 1992; 18: 171–176.
15.Neale, MC, Cardon, LR. Methodology for Genetic Studies of Twins and Families. Dordrecht: Kluwer Academic Publishers, 1992.
16.Falconer, DS. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Annals of Human Genetics 1965; 29: 51–76.
17.Neale, MC, et al. Mx: Statistical Modeling. 5th edn. Box 126 MCV, Richmond, VA 23298: Department of Psychiatry; 1999.
18.Lindsey, JK, Jones, B. Choosing among generalized linear models applied to medical data. Statistics in Medicine 1998; 17: 59–68.
19.Schottstedt, V, et al. Human cytomegalovirus (HCMV) – revised. Transfusion Medicine and Hemotherapy 2010; 37: 365–375.
20.Stelma, FF, et al. Occupational risk of human cytomegalovirus and parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence. European Jounal of Clinical Microbiology and Infectious Diseases 2009; 28: 393–397.
21.Christiansen, L, et al. Age- and sex-differences in the validity of questionnaire-based zygosity in twins. Twin Research 2003; 6: 275–278.